Christina Lake Cannabis AI Stock Analysis
Want to see TSE:CLC full AI Analyst Report?
Christina Lake Cannabis (CLC) AI Stock Analysis
Christina Lake Cannabis
(CNQX:CLC)
The overall score is severely depressed by the company's return to unprofitability and cash burn in the TTM period, which is the most significant risk. This fundamental weakness is compounded by a bearish technical trend and a negative P/E ratio that reflects the lack of current earnings. The company's fragile financial health and inability to consistently generate cash are the primary drivers of the low score.
Christina Lake Cannabis (CLC) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 5.21M
- Dividend Yield
- ―
- Average Volume (3M)
- 61.86K
- Price to Earnings (P/E)
- -3.2
- Beta (1Y)
- -0.22
- Revenue Growth
- -3.64%
- EPS Growth
- -2.63%
- Country
- Canada
- Employees
- 8
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Drug Manufacturers - Specialty & Generic
Christina Lake Cannabis Business Overview & Revenue Model
Company Description
Operating out of British Columbia, Canada, Christina Lake Cannabis Corp. is engaged in the cultivation, processing, and distribution of a variety of cannabis products. Its portfolio features cannabis oil, hemp oil, other cannabis and hemp derivatives...
Christina Lake Cannabis Financial Statement Overview
Summary
Financial performance is critically weak. The TTM period shows a gross loss, substantial net loss, and minimal operating cash flow, indicating unstable operations and poor cash conversion. While the balance sheet has improved leverage, deeply negative returns on equity and collapsing free cash flow present a high-risk profile.
Income Statement
28NegativeBalance Sheet
45NeutralCash Flow
22Negative| Breakdown | TTM | Nov 2025 | Nov 2024 | May 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.61M | 15.08M | 13.61M | 11.78M | 10.07M | 3.63M |
| Gross Profit | -1.82M | 1.94M | 9.31M | 3.61M | 2.98M | 56.72K |
| EBITDA | -3.85M | 2.92M | 3.25M | -2.62M | -938.92K | -5.97M |
| Net Income | -2.03M | 1.10M | 865.00K | -4.13M | -1.74M | -6.78M |
Balance Sheet | ||||||
| Total Assets | 24.47M | 28.02M | 23.37M | 15.96M | 18.79M | 18.97M |
| Cash, Cash Equivalents and Short-Term Investments | 1.46M | 1.67M | 1.85M | 1.47M | 1.84M | 1.08M |
| Total Debt | 7.30M | 8.74M | 10.27M | 6.15M | 6.45M | 3.81M |
| Total Liabilities | 9.74M | 11.18M | 12.57M | 8.50M | 7.66M | 9.23M |
| Stockholders Equity | 14.73M | 16.84M | 10.79M | 7.46M | 11.14M | 9.74M |
Cash Flow | ||||||
| Free Cash Flow | 141.82K | 4.68M | -4.13M | 781.46K | 394.55K | -5.85M |
| Operating Cash Flow | 587.98K | 2.68M | 221.02K | 1.38M | 1.18M | -4.62M |
| Investing Cash Flow | 99.64K | 2.19M | -4.47M | -571.37K | -790.41K | -1.20M |
| Financing Cash Flow | -1.54M | -5.06M | 4.59M | -1.15M | 369.17K | 5.06M |
Christina Lake Cannabis Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CLC, the sentiment is Negative. The current price of 0.03 is below the 20-day moving average (MA) of 0.03, below the 50-day MA of 0.03, and below the 200-day MA of 0.03, indicating a bearish trend. The MACD of -0.00 indicates Negative momentum. The RSI at 42.37 is Neutral, neither overbought nor oversold. The STOCH value of is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:CLC.
Christina Lake Cannabis Peers Comparison
Overall Rating
TSE:TGIF45Neutral
TSE:AVNT44Neutral
TSE:BBM44Neutral
TSE:OILS43Neutral
TSE:CLC38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 45Neutral | CAD 5.21M | 6.25 | -11.60% | ― | -4.90% | ― | |
| 44Neutral | CAD 8.03M | -0.66 | -43.60% | ― | -15.88% | 59.93% | |
| 44Neutral | CAD 4.95M | -4.76 | -332.63% | ― | -36.67% | 40.54% | |
| 43Neutral | CAD 3.40M | -1.75 | -43.92% | ― | -18.30% | -397.37% | |
| 38Underperform | CAD 6.20M | -3.25 | -16.06% | ― | -3.64% | -2.63% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:CLC | Christina Lake Cannabis Corp | 0.03 | -0.01 | -28.57% | |
| TSE:TGIF | 1933 Industries, Inc. | 0.01 | 0.00 | 0.00% | |
| TSE:BBM | Blueberries Medical | 0.01 | -0.01 | -50.00% | |
| TSE:AVNT | Avant Brands Inc | 0.52 | -0.14 | -21.21% | |
| TSE:OILS | Nextleaf Solutions | 0.02 | -0.03 | -60.00% | |
| TSE:HASH | Simply Solventless Concentrates Ltd | 0.04 | -0.18 | -81.82% |
Christina Lake Cannabis Corporate Events
Christina Lake Cannabis Secures New $1.5 Million Credit Facility
NeutralChristina Lake Cannabis has entered into a secured revolving credit facility of up to $1.5 million with an entity controlled by company director Salvatore Milia. The facility has a two-year term, carries 14% annual interest on outstanding amounts and...
Christina Lake Cannabis Enters Talks on $15 Million Takeover
PositiveChristina Lake Cannabis has signed a non-binding letter of intent with a private Alberta corporation that contemplates the acquisition of all its outstanding common shares. The proposed deal assigns an aggregate transaction value of $15 million on a...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 04, 2026
